Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 30, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

[Bladder cancer: news in 2008].

J Irani1, A Descazeaud

  • 1Service d'Urologie, CHU la Milétrie, 2 rue de la Milétrie, Poitiers cedex, France. j.irani@chu-poitiers.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|November 26, 2008
PubMed
Summary

Innovations in urothelial cancer management were presented in 2007. Key updates include new treatments for non-muscle-invading bladder tumors and advancements in upper tract urothelial carcinoma and infiltrating bladder cancer care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and morbidity of sacrocolpopexy: Robot (RASC) vs Laparoscopy (LSC), A retrospective, monocentric multi-departmental study.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Management of high-grade papillary Ta or T1 bladder cancer after restaging transurethral resection: A retrospective study comparing Bacillus Calmette-Guerin therapy upfront versus a third resection.

The French journal of urology·2023
Same author

[Complications in urological surgery].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Complications in urological surgery: Monitoring and classification].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Complications in urological surgery. Prevention].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Complications of radical nephrectomy and partial nephrectomy: What are they? How can they be anticipated and managed?]

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Area of Science:

  • Urology
  • Oncology
  • Surgical Innovation

Context:

  • 2007 international conferences highlighted diverse urothelial cancer communications.
  • Focus on studies with potential to significantly alter patient management.
  • Advances span non-muscle-invading, upper tract, and infiltrating bladder tumors.

Purpose:

  • To review and synthesize key innovations in urothelial cancer treatment presented in 2007.
  • To identify emerging trends in patient management for various stages of urothelial cancers.
  • To assess the impact of new therapeutic strategies and surgical techniques.

Summary:

  • Maintenance intravesical instillations were emphasized for non-muscle-invading urothelial tumors.
  • Laser and laparoscopic approaches were evaluated for upper urinary tract urothelial tumors.

More Related Videos

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

Related Experiment Videos

Last Updated: Jun 30, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 6, 2011

  • New radiochemotherapy protocols and extended lymphadenectomy with laparoscopy were detailed for infiltrating bladder tumors.

    • Impact:

    • These advancements signal a shift towards more tailored and less invasive treatment options.
    • The reviewed studies offer potential for improved patient outcomes and quality of life.
    • The integration of novel techniques like laparoscopy and advanced chemoradiation broadens therapeutic possibilities.